title: The effect of pharmaceutical benefits managers: is it being evaluated?
abstract: Over the last decade, the number of pharmaceutical benefits managers has increased, and their influence has expanded rapidly. These managers now provide prescription drug coverage to more than 100 million Americans. The effect of pharmaceutical benefits managers on health care delivery remains unclear. We review the development of these organizations, their current role in the delivery of pharmaceutical therapies to patients, and their relationship with pharmaceutical manufacturers. We discuss potential advantages and disadvantages of pharmaceutical benefits manager practices and suggest ways in which these organizations can be made more accountable to the employer groups that hire them.
authors.affiliation: Clinical Economics Research Unit, Georgetown University Medical Center, Washington, DC 20007, USA.
authors.forename: K A
authors.initials: KA
authors.lastname: Schulman
authors.forename: L E
authors.initials: LE
authors.lastname: Rubenstein
authors.forename: D R
authors.initials: DR
authors.lastname: Abernethy
authors.forename: D M
authors.initials: DM
authors.lastname: Seils
authors.forename: D P
authors.initials: DP
authors.lastname: Sulmasy
mesh_terms: D000288:Administrative Personnel; D019090:Case Management; D016265:Conflict of Interest; D003625:Data Collection; D004345:Drug Industry; D017723:Drug Utilization Review; D005569:Formularies as Topic; D006264:Health Benefit Plans, Employee / Q000706:statistics & numerical data; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000592:standards / Q000706:statistics & numerical data*; D008329:Managed Care Programs; D010565:Persuasive Communication; D014481:United States